174 related articles for article (PubMed ID: 12639886)
1. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
Rasheed A; Simpson J; Rosenthal E
Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
[No Abstract] [Full Text] [Related]
2. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
Hall CM; Ward Platt MP
Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
[No Abstract] [Full Text] [Related]
3. When potion becomes poison! A case report of flecainide toxicity.
Bajaj S; Tullu MS; Khan Z; Agrawal M
J Postgrad Med; 2017; 63(4):265-267. PubMed ID: 28272074
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of supraventricular tachycardia with flecainide acetate: a case report.
Amano K; Harada Y; Shoda T; Nishijima M; Hiraishi S
Fetal Diagn Ther; 1997; 12(6):328-31. PubMed ID: 9475360
[TBL] [Abstract][Full Text] [Related]
5. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
Campbell JQ; Best TH; Eswaran H; Lowery CL
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
[TBL] [Abstract][Full Text] [Related]
6. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.
Sridharan S; Sullivan I; Tomek V; Wolfenden J; Škovránek J; Yates R; Janoušek J; Dominguez TE; Marek J
Heart Rhythm; 2016 Sep; 13(9):1913-9. PubMed ID: 27554948
[TBL] [Abstract][Full Text] [Related]
7. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
[No Abstract] [Full Text] [Related]
8. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
[TBL] [Abstract][Full Text] [Related]
9. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction.
Cuneo BF; Benson DW
Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734
[No Abstract] [Full Text] [Related]
10. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis.
Barjot P; Hamel P; Calmelet P; Maragnes P; Herlicoviez M
Acta Obstet Gynecol Scand; 1998 Mar; 77(3):353-8. PubMed ID: 9539287
[No Abstract] [Full Text] [Related]
11. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, treatment, observation and outcome of fetal supraventricular tachycardia in a twin pregnancy.
Schiermeier S; van Leeuwen P; Reinhard J; Gronemeyer D; Hatzmann W
Fetal Diagn Ther; 2008; 24(4):327-30. PubMed ID: 18836269
[TBL] [Abstract][Full Text] [Related]
13. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
[TBL] [Abstract][Full Text] [Related]
14. Flecainide induced ventricular fibrillation in a neonate.
Ackland F; Singh R; Thayyil S
Heart; 2003 Oct; 89(10):1261. PubMed ID: 12975443
[No Abstract] [Full Text] [Related]
15. Successful management of supraventricular tachycardia in a fetus using fetal magnetocardiography.
Abe K; Hamada H; Chen YJ; Abe A; Watanabe H; Fujiki Y; Yoshikawa H; Murakami T; Horigome H
Fetal Diagn Ther; 2005; 20(5):459-62. PubMed ID: 16113573
[TBL] [Abstract][Full Text] [Related]
16. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy.
Edwards A; Peek MJ; Curren J
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):110-2. PubMed ID: 10099764
[TBL] [Abstract][Full Text] [Related]
17. Haemolysis alters plasma flecainide levels in newborn infants.
Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
[TBL] [Abstract][Full Text] [Related]
19. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
20. Flecainide as first-line treatment for fetal supraventricular tachycardia.
Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
